Angelique Schyns-Soeterboek

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Acute Cognitive Effects of Nonconvulsive Difficult-to-Detect Epileptic Seizures and Epileptiform Electroencephalographic Discharges

J. Arends, A. Aldenkamp, L. Diepman, 2001, Journal of child neurology.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Hester F. Lingsma, E. Steyerberg, R. Hughes, 2021, The Lancet Neurology.